🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalCanadian GLP-1 coverage — 12 month update Page 5

Canadian GLP-1 coverage — 12 month update

Dr.SleepRoch Tue, Dec 17, 2024 at 4:46 AM 52 replies 2,746 viewsPage 5 of 11
maya_sedona
Member
289
1,234
Sep 2024
Sedona, AZ
Dec 19, 2024 at 6:47 PM#21

Following on from Dr.AddMedPHL — and this may be the naive question:

What did you change at the same time, and can you separate the two now?

15 13wanda_boise, NurseAsh_DET, BenResearch_OR and 12 others
Reply Quote Save Share Report
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Dec 20, 2024 at 2:33 AM#22
KristenIndy said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

16 14Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 13 others
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Dec 20, 2024 at 10:19 AM#23
KristenIndy said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

Last edited: Dec 20, 2024 at 1:19 PM
17 15MaxMetOK, MounjBrad, nick_newbie and 14 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
BenResearch_OR
Senior Member
2,456
11,234
Dec 2023
Oregon
Dec 20, 2024 at 6:05 PM#24
KristenIndy said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Genuinely useful, thank you. I had the facts and not the framework. Printing the relevant bit and taking it with me.

Last edited: Dec 20, 2024 at 7:05 PM
18 16Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 15 others
Reply Quote Save Share Report
traveltech_sara
Member
156
678
Jan 2025
Remote, USA
Dec 21, 2024 at 1:51 AM#25

Clinical perspective, offered as context rather than as advice. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

Correct me if the detail matters more than I have assumed.

Last edited: Dec 21, 2024 at 4:51 AM
19 17BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 16 others
Reply Quote Save Share Report
13456711

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register